Xcorporeal (Xcorporeal) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of May. 27, 2024)

View and export this data going back to . Start your Free Trial

What is Xcorporeal EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Medical Devices subindustry, Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.

Xcorporeal (GREY:XCRP) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Xcorporeal EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Xcorporeal's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Xcorporeal (Xcorporeal) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xcorporeal Inc (GREY:XCRP) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Empire Drive, Lake Forest, CA, USA, 92630

Website

Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.

Executives

Kelly J. Mccrann	director, officer: Chairman and CEO	11150 SANTA MONICA BLVD #1500, LOS ANGELES CA 90025
Daniel S Goldberger	officer: Chief Executive Officer	24 CARPENTER ROAD, CHESTER NY 10918
Marc G Cummins	director	C/O PRIME LOGIC CAPITAL, LLC, 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Prime Logic Capital, Llc	10 percent owner	135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Robert Weinstein	officer: Chief Financial Officer	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Terren S Peizer	director, 10 percent owner, officer: Executive Chairman	11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Jay Wolf	director	981 LINDA FLORA DRIVE, LOS ANGELES, CA 90049
Herve De Kergrohen	director	22 CHEMIN DU NANTET, COLLONGE-BELLERIVE V8 CH1245
Nicholas Sheridan Lewin	director	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Lawrence Lacerte	10 percent owner	C/O TERAGLOBAL COMMUNICATIONS CORP, 9171 TOWNE CENTRE DRIVE SUITE 600, SAN DIEGO CA 92122